Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was EGP 302.65 million compared to EGP 257.23 million a year ago. Net income was EGP 27.56 million compared to EGP 9.58 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
77.05 EGP | -3.25% | -13.93% | +22.87% |
1st Jan change | Capi. | |
---|---|---|
+22.87% | 9.25M | |
+31.37% | 588B | |
-3.11% | 364B | |
+19.56% | 326B | |
+5.17% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.63% | 167B | |
+0.51% | 161B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2022